Ablatherm Integrated Imaging

GUDID 03661690000144

The device is a computer-controlled medical device intended to provide High Intensity Focused Ultrasound (also referred to as HIFU) to ablate prostate tissue. The system consists of the following main sub-assemblies: Therapy Control Module, Treatment Module, Endorectal Probe, and consumable Ablapak. HIFU is a unique process of delivering a large amount of heat energy to a confined space in a highly controlled manner. This energy heats the tissue to ablation levels while minimizing the effect on surrounding structures. The ultrasound energy is delivered via an endorectal probe, which includes an imaging system. The ultrasound waves propagate through the rectal wall and are focused on a portion of the prostate, generating intense heat and causing the ablation of tissue within the targeted area. The process is then repeated in a stepwise fashion to destroy the targeted tissues within the prostate. The apex, sphincter and rectum are preserved while prostate tissues are ablated.

EDAP-TMS FRANCE

Physical therapy ultrasound system
Primary Device ID03661690000144
NIH Device Record Key7a37bc0d-100a-4adf-993d-d43708b181d8
Commercial Distribution Discontinuation2019-12-31
Commercial Distribution StatusNot in Commercial Distribution
Brand NameAblatherm Integrated Imaging
Version Model NumberEDP900800
Company DUNS383113362
Company NameEDAP-TMS FRANCE
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com
Phone512 832-7956
Emailcontact@edap-usa.com

Device Identifiers

Device Issuing AgencyDevice ID
GS103661690000144 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

PLPHigh Intensity Ultrasound System For Prostate Tissue Ablation

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number4
Public Version Date2024-12-11
Device Publish Date2016-09-21

Devices Manufactured by EDAP-TMS FRANCE

03661690000014 - Ablapak2024-12-11 The Ablapak is he single use kit of consumables to support a single patient procedure using the Ablatherm Integrated Imaging sys
03661690000076 - Ablatherm Endorectal Probe2024-12-11 The Ablatherm Endorectal Probe is a primary component of the Ablatherm Integrated Imaging system which is a computer-controlled
03661690000083 - Sonolith Carbon Fiber Table2024-12-11 One piece carbon fiber table for use with SONOLITH® i-move or i-sys lithotripsy devices for ESWL(Extracorporeal Shock Wave Lith
03661690000090 - Endo-i-move Table2024-12-11 A table for use with the SONOLITH® i-move medical device is a lithotripter of ESWL type (Extracorporeal Shock Wave Lithotripsy)
03661690000106 - Sonolith i-move Standard Module2024-12-11 SONOLITH® i-move medical device is a lithotripter of ESWL type (Extracorporeal Shock Wave Lithotripsy). The physical principle
03661690000113 - Sonolith i-move Visio-Track Module2024-12-11 SONOLITH® i-move Visio-Track medical device is a lithotripter of ESWL type (Extracorporeal Shock Wave Lithotripsy). The physica
03661690000120 - Sonolith i-move Touch Module2024-12-11 SONOLITH® i-move Touch medical device is a lithotripter of ESWL type (Extracorporeal Shock Wave Lithotripsy). The physical prin
03661690000144 - Ablatherm Integrated Imaging2024-12-11The device is a computer-controlled medical device intended to provide High Intensity Focused Ultrasound (also referred to as HIFU) to ablate prostate tissue. The system consists of the following main sub-assemblies: Therapy Control Module, Treatment Module, Endorectal Probe, and consumable Ablapak. HIFU is a unique process of delivering a large amount of heat energy to a confined space in a highly controlled manner. This energy heats the tissue to ablation levels while minimizing the effect on surrounding structures. The ultrasound energy is delivered via an endorectal probe, which includes an imaging system. The ultrasound waves propagate through the rectal wall and are focused on a portion of the prostate, generating intense heat and causing the ablation of tissue within the targeted area. The process is then repeated in a stepwise fashion to destroy the targeted tissues within the prostate. The apex, sphincter and rectum are preserved while prostate tissues are ablated.
03661690000144 - Ablatherm Integrated Imaging2024-12-11 The device is a computer-controlled medical device intended to provide High Intensity Focused Ultrasound (also referred to as HI

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.